Microbial Study of Sublingual Immunotherapy Spray in Patients With Allergic Rhinitis

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Rhinitis, Allergic

Interventions

DRUG

Patients desensitized by sublingual spray

Drug: Oraltekzc®️(Canis familiari), Oraltek®️(Felis domesticus), Oraltek®️(Alternaria alternata), dosage form: sublingual spray.

Trial Locations (1)

The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT06741787 - Microbial Study of Sublingual Immunotherapy Spray in Patients With Allergic Rhinitis | Biotech Hunter | Biotech Hunter